FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial - Concepedia

Concepedia

Publication | Open Access

FOLFOXIRI plus bevacizumab versus FOLFOX plus bevacizumab for patients with metastatic colorectal cancer and ≥3 circulating tumour cells: the randomised phase III VISNÚ-1 trial

DOI Full Paper Access

59

Citations

18

References

2020

Year

Enrique Aranda, José María Viéitez, Auxiliadora Gómez‐España, Silvia Gil Calle, Antonieta Salud, Begoña Graña, Pilar García‐Alfonso, Fernando Rivera, Guillermo Alfonso Quintero-Aldana, Juan José Reina-Zoilo,

References

	Year	Citations

Page 1